*Sites Only Session
Learn how your Site can be Diversity and Digitally Enabled
Come to the symposium to learn more about solutions and strategies your site can adopt, share your feedback on challenges, and let us know what you need from industry to be successful.
*Sites Only Session
Leveraging Site and Patient Experiences to Build Inclusive, Decentralized Clinical Strategies
Join us for a candid and interactive session to share your experiences and expertise on decentralized clinical trial strategies to meet patients where they are, minimize burden, and integrate diversity initiatives.
*Sites Only Session
Freeing Sites to do the Extraordinary
Sites need more time and resources. Time to spend with patients. Resources to be more efficient. Join IQVIA at our annual Site Partnership Symposium to make connections that make a difference. You will hear from business unit leaders across the company whose roles are to help make your site successful and free you to do the extraordinary things for your patients.
*Sites Only Session
An Exploration of Technological Advancement and the Impact on Sites
Over the past several years, the clinical research industry has seen an unprecedented rise in technological solutions to clinical operations problems. Whether it was the “COVID pivot”, pressure for efficiency, or just plain technological evolution, sponsors and CROs have searched high and low for the perfect use of digital health in the administration of clinical trials, and this is not a trend that will change anytime soon.
But how are we doing? Is it helping? And where should we go from here? After a brief highlight of Janssen’s efforts in digital health innovation, an interactive session will focus on the impact that technology has on sites, the challenges from a site perspective, areas of opportunity, and what actions sponsors can take to improve the overall site experience.
During the breakout session, site participants and Janssen staff will openly discuss specific topics related to digital health. Together, we will consider what factors of technological innovation have the greatest opportunity to improve overall clinical trial experience for sites.
SPEAKERS
Sean Cunningham, Strategic Account Lead Director, Global Clinical Operations US, Janssen
Sandy Freeman, Director – IDV-CVMR/PH, Global Clinical Operations US, Janssen
